APO Research
Talk to an analyst

APO RESEARCH · REPORT

Type 2 Diabetes Mellitus Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Type 2 Diabetes Mellitus Treatment Market Analysis and Forecast 2026-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchType 2 Diabetes Mellitus Treatment Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 2 Diabetes Mellitus Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Type 2 Diabetes Mellitus Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 2 Diabetes Mellitus Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 2 Diabetes Mellitus Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Type 2 Diabetes Mellitus Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Type 2 Diabetes Mellitus Treatment include Takeda Pharmaceutical Co. Ltd, Sanofi SA, Novartis AG, Novo Nordisk AS, Merck & Co. Inc, Eli Lilly and Co., Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH and AstraZeneca PLC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Type 2 Diabetes Mellitus Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Type 2 Diabetes Mellitus Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Type 2 Diabetes Mellitus Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Type 2 Diabetes Mellitus Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Type 2 Diabetes Mellitus Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Type 2 Diabetes Mellitus Treatment revenue, projected growth trends, production technology, application and end-user industry.

Type 2 Diabetes Mellitus Treatment Segment by Company

Takeda Pharmaceutical Co. Ltd

Sanofi SA

Novartis AG

Novo Nordisk AS

Merck & Co. Inc

Eli Lilly and Co.

Daiichi Sankyo Co. Ltd

Boehringer Ingelheim International GmbH

AstraZeneca PLC

Type 2 Diabetes Mellitus Treatment Segment by Type

Insulin

SGLT2 Inhibitors

GLP-1 Receptor Agonists

DPP-4 Inhibitors

Others

Type 2 Diabetes Mellitus Treatment Segment by Application

Hospitals

Clinics

Other

Type 2 Diabetes Mellitus Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes Mellitus Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes Mellitus Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes Mellitus Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Type 2 Diabetes Mellitus Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Type 2 Diabetes Mellitus Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Type 2 Diabetes Mellitus Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Insulin Major Player Table 3. SGLT2 Inhibitors Major Player Table 4. GLP-1 Receptor Agonists Major Player Table 5. DPP-4 Inhibitors Major Player Table 6. Others Major Player Table 7. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Player Table 9. Clinics Major Player Table 10. Other Major Player Table 11. Type 2 Diabetes Mellitus Treatment Industry Trends Table 12. Type 2 Diabetes Mellitus Treatment Industry Drivers Table 13. Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges Table 14. Type 2 Diabetes Mellitus Treatment Industry Restraints Table 15. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2021-2026) Table 18. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2027-2032) Table 20. Global Type 2 Diabetes Mellitus Treatment Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Players (2021-2026) Table 22. Global Type 2 Diabetes Mellitus Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Type 2 Diabetes Mellitus Treatment Key Players Headquarters & Area Served Table 24. Global Type 2 Diabetes Mellitus Treatment Players, Product Type & Application Table 25. Global Type 2 Diabetes Mellitus Treatment Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Type 2 Diabetes Mellitus Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Type 2 Diabetes Mellitus Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2027-2032) Table 33. Global Type 2 Diabetes Mellitus Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2021-2026) Table 37. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2027-2032) Table 38. Takeda Pharmaceutical Co. Ltd Company Information Table 39. Takeda Pharmaceutical Co. Ltd Business Overview Table 40. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 42. Takeda Pharmaceutical Co. Ltd Recent Development Table 43. Sanofi SA Company Information Table 44. Sanofi SA Business Overview Table 45. Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio Table 47. Sanofi SA Recent Development Table 48. Novartis AG Company Information Table 49. Novartis AG Business Overview Table 50. Novartis AG Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio Table 52. Novartis AG Recent Development Table 53. Novo Nordisk AS Company Information Table 54. Novo Nordisk AS Business Overview Table 55. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio Table 57. Novo Nordisk AS Recent Development Table 58. Merck & Co. Inc Company Information Table 59. Merck & Co. Inc Business Overview Table 60. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio Table 62. Merck & Co. Inc Recent Development Table 63. Eli Lilly and Co. Company Information Table 64. Eli Lilly and Co. Business Overview Table 65. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio Table 67. Eli Lilly and Co. Recent Development Table 68. Daiichi Sankyo Co. Ltd Company Information Table 69. Daiichi Sankyo Co. Ltd Business Overview Table 70. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 72. Daiichi Sankyo Co. Ltd Recent Development Table 73. Boehringer Ingelheim International GmbH Company Information Table 74. Boehringer Ingelheim International GmbH Business Overview Table 75. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio Table 77. Boehringer Ingelheim International GmbH Recent Development Table 78. AstraZeneca PLC Company Information Table 79. AstraZeneca PLC Business Overview Table 80. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio Table 82. AstraZeneca PLC Recent Development Table 83. North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026) & (US$ Million) Table 89. North America Type 2 Diabetes Mellitus Treatment Revenue by Country (US$ Million) & (2027-2032) Table 90. Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (US$ Million) & (2027-2032) Table 97. China Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026) & (US$ Million) Table 98. China Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032) & (US$ Million) Table 99. China Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026) & (US$ Million) Table 100. China Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032) & (US$ Million) Table 101. Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026) & (US$ Million) Table 102. Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032) & (US$ Million) Table 103. Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026) & (US$ Million) Table 104. Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Type 2 Diabetes Mellitus Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Asia Type 2 Diabetes Mellitus Treatment Revenue by Region (US$ Million) & (2021-2026) Table 107. Asia Type 2 Diabetes Mellitus Treatment Revenue by Region (US$ Million) & (2027-2032) Table 108. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026) & (US$ Million) Table 109. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032) & (US$ Million) Table 110. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026) & (US$ Million) Table 111. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032) & (US$ Million) Table 112. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026) & (US$ Million) Table 114. SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (US$ Million) & (2027-2032) Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Type 2 Diabetes Mellitus Treatment Image Figure 2. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 2 Diabetes Mellitus Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Insulin Image Figure 5. SGLT2 Inhibitors Image Figure 6. GLP-1 Receptor Agonists Image Figure 7. DPP-4 Inhibitors Image Figure 8. Others Image Figure 9. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Type 2 Diabetes Mellitus Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Other Image Figure 14. Global Type 2 Diabetes Mellitus Treatment Market Size (US$ Million) & (2021-2032) Figure 15. Global Type 2 Diabetes Mellitus Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Type 2 Diabetes Mellitus Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Type 2 Diabetes Mellitus Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032) Figure 27. North America Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032) Figure 28. North America Type 2 Diabetes Mellitus Treatment Revenue Share by Country (2021-2032) Figure 29. United States Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032) Figure 34. Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032) Figure 35. Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Country (2021-2032) Figure 36. Germany Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032) Figure 46. China Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032) Figure 49. Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032) Figure 50. Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Region (2021-2032) Figure 51. Japan Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032) Figure 59. SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032) Figure 60. SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Country (2021-2032) Figure 61. Brazil Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Type 2 Diabetes Mellitus Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • SGLT2 Inhibitors
  • GLP-1 Receptor Agonists
  • DPP-4 Inhibitors
  • Others
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Co. Ltd
  • Sanofi SA
  • Novartis AG
  • Novo Nordisk AS
  • Merck & Co. Inc
  • Eli Lilly and Co.
  • Daiichi Sankyo Co. Ltd
  • Boehringer Ingelheim International GmbH
  • AstraZeneca PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Type 2 Diabetes Mellitus Treatment Market by Type
  3. 1.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin
  5. 1.2.3 SGLT2 Inhibitors
  6. 1.2.4 GLP-1 Receptor Agonists
  7. 1.2.5 DPP-4 Inhibitors
  8. 1.2.6 Others
  9. 1.3 Type 2 Diabetes Mellitus Treatment Market by Application
  10. 1.3.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Type 2 Diabetes Mellitus Treatment Market Dynamics
  1. 2.1 Type 2 Diabetes Mellitus Treatment Industry Trends
  2. 2.2 Type 2 Diabetes Mellitus Treatment Industry Drivers
  3. 2.3 Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges
  4. 2.4 Type 2 Diabetes Mellitus Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Type 2 Diabetes Mellitus Treatment Market Perspective (2021-2032)
  2. 3.2 Global Type 2 Diabetes Mellitus Treatment Growth Trends by Region
  3. 3.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Players
  2. 4.1.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Type 2 Diabetes Mellitus Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Type 2 Diabetes Mellitus Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Type 2 Diabetes Mellitus Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Type 2 Diabetes Mellitus Treatment Players, Product Type & Application
  8. 4.5 Global Type 2 Diabetes Mellitus Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Type 2 Diabetes Mellitus Treatment Market CR5 and HHI
  11. 4.6.3 2025 Type 2 Diabetes Mellitus Treatment Tier 1, Tier 2, and Tier 3
5 Type 2 Diabetes Mellitus Treatment Market Size by Type
  1. 5.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2021-2032)
6 Type 2 Diabetes Mellitus Treatment Market Size by Application
  1. 6.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Co. Ltd
  2. 7.1.1 Takeda Pharmaceutical Co. Ltd Company Information
  3. 7.1.2 Takeda Pharmaceutical Co. Ltd Business Overview
  4. 7.1.3 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Co. Ltd Recent Developments
  7. 7.2 Sanofi SA
  8. 7.2.1 Sanofi SA Company Information
  9. 7.2.2 Sanofi SA Business Overview
  10. 7.2.3 Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio
  12. 7.2.5 Sanofi SA Recent Developments
  13. 7.3 Novartis AG
  14. 7.3.1 Novartis AG Company Information
  15. 7.3.2 Novartis AG Business Overview
  16. 7.3.3 Novartis AG Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio
  18. 7.3.5 Novartis AG Recent Developments
  19. 7.4 Novo Nordisk AS
  20. 7.4.1 Novo Nordisk AS Company Information
  21. 7.4.2 Novo Nordisk AS Business Overview
  22. 7.4.3 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio
  24. 7.4.5 Novo Nordisk AS Recent Developments
  25. 7.5 Merck & Co. Inc
  26. 7.5.1 Merck & Co. Inc Company Information
  27. 7.5.2 Merck & Co. Inc Business Overview
  28. 7.5.3 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio
  30. 7.5.5 Merck & Co. Inc Recent Developments
  31. 7.6 Eli Lilly and Co.
  32. 7.6.1 Eli Lilly and Co. Company Information
  33. 7.6.2 Eli Lilly and Co. Business Overview
  34. 7.6.3 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio
  36. 7.6.5 Eli Lilly and Co. Recent Developments
  37. 7.7 Daiichi Sankyo Co. Ltd
  38. 7.7.1 Daiichi Sankyo Co. Ltd Company Information
  39. 7.7.2 Daiichi Sankyo Co. Ltd Business Overview
  40. 7.7.3 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  42. 7.7.5 Daiichi Sankyo Co. Ltd Recent Developments
  43. 7.8 Boehringer Ingelheim International GmbH
  44. 7.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 7.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 7.8.3 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio
  48. 7.8.5 Boehringer Ingelheim International GmbH Recent Developments
  49. 7.9 AstraZeneca PLC
  50. 7.9.1 AstraZeneca PLC Company Information
  51. 7.9.2 AstraZeneca PLC Business Overview
  52. 7.9.3 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio
  54. 7.9.5 AstraZeneca PLC Recent Developments
8 North America
  1. 8.1 North America Type 2 Diabetes Mellitus Treatment Revenue (2021-2032)
  2. 8.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Type 2 Diabetes Mellitus Treatment Revenue by Country
  11. 8.6.1 North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Type 2 Diabetes Mellitus Treatment Revenue (2021-2032)
  2. 9.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country
  11. 9.6.1 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Type 2 Diabetes Mellitus Treatment Revenue (2021-2032)
  2. 10.2 China Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032)
  5. 10.3 China Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032)
  9. 10.5 China Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Type 2 Diabetes Mellitus Treatment Revenue (2021-2032)
  2. 11.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country
  11. 11.6.1 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country
  11. 12.6.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst